John Alexander Kelly - Jun 7, 2023 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role
Chief Financial Officer
Signature
John Alexander Kelly
Stock symbol
DTIL
Transactions as of
Jun 7, 2023
Transactions value $
$0
Form type
4
Date filed
6/9/2023, 04:15 PM
Previous filing
Mar 21, 2023
Next filing
Oct 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DTIL Common Stock Options Exercise +34.1K +13.88% 280K Jun 7, 2023 Direct F1, F2
transaction DTIL Common Stock Options Exercise +13.6K +4.87% 293K Jun 7, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DTIL Restricted Stock Units Options Exercise $0 -34.1K -100% $0.00* 0 Jun 7, 2023 Common Stock 34.1K Direct F2, F3
transaction DTIL Restricted Stock Units Options Exercise $0 -13.6K -50% $0.00 13.6K Jun 7, 2023 Common Stock 13.6K Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2023.
F2 Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.
F3 On June 7, 2021 the Reporting Person was granted RSUs, which vest in two substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
F4 On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.